31 related articles for article (PubMed ID: 3154706)
1. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
Talbert RL
Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
[TBL] [Abstract][Full Text] [Related]
2. Influence of nitrendipine and verapamil on plasma levels, urinary excretion, and beta-blocking effect of metoprolol.
Kirch W; Santos SR; Geller M; Mönig H; Stenzel J; Ohnhaus EE
Cardiovasc Drugs Ther; 1988 Jul; 2(2):205-9. PubMed ID: 3154706
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
[TBL] [Abstract][Full Text] [Related]
4. Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
Bailey DG; Carruthers SG
Clin Pharmacol Ther; 1991 Apr; 49(4):370-6. PubMed ID: 2015727
[TBL] [Abstract][Full Text] [Related]
5. Effect of metoprolol and verapamil administered separately and concurrently after single doses on liver blood flow and drug disposition.
Bauer LA; Horn JR; Maxon MS; Easterling TR; Shen DD; Strandness DE
J Clin Pharmacol; 2000 May; 40(5):533-43. PubMed ID: 10806607
[TBL] [Abstract][Full Text] [Related]
6. Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.
Laurent-Kenesi MA; Funck-Brentano C; Poirier JM; Decolin D; Jaillon P
Br J Clin Pharmacol; 1993 Dec; 36(6):531-8. PubMed ID: 12959269
[TBL] [Abstract][Full Text] [Related]
7. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
[TBL] [Abstract][Full Text] [Related]
9. HPLC determination of antipyrine metabolites.
Eichelbaum M; Sonntag B; Dengler HJ
Pharmacology; 1981; 23(4):192-202. PubMed ID: 7323136
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of metoprolol.
Regårdh CG; Johnsson G
Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
[No Abstract] [Full Text] [Related]
11. Rapid determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by high-performance liquid chromatography.
Lennard MS; Silas JH
J Chromatogr; 1983 Jan; 272(1):205-9. PubMed ID: 6841542
[No Abstract] [Full Text] [Related]
12. Calcium-channel-blocking agents.
Insel PA; Motulsky HJ
N Engl J Med; 1983 Jun; 308(22):1361-2. PubMed ID: 6302509
[No Abstract] [Full Text] [Related]
13. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium.
Karliner JS; Motulsky HJ; Dunlap J; Brown JH; Insel PA
J Cardiovasc Pharmacol; 1982; 4(3):515-20. PubMed ID: 6177951
[TBL] [Abstract][Full Text] [Related]
14. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
